In vitro transcription for RNA vaccines and therapeutics: a quality-by-design perspective on manufacturability

Adithya Nair, Zoltán Kis

Open source

DOI
10.1016/j.biotechadv.2026.109034
Published
2026-12
Container
Biotechnology Advances
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biotechadv.2026.109034,
  title = {In vitro transcription for RNA vaccines and therapeutics: a quality-by-design perspective on manufacturability},
  author = {Adithya Nair and Zoltán Kis},
  year = {2026},
  journal = {Biotechnology Advances},
  doi = {10.1016/j.biotechadv.2026.109034},
  url = {https://doi.org/10.1016/j.biotechadv.2026.109034}
}

RIS

TY  - JOUR
TI  - In vitro transcription for RNA vaccines and therapeutics: a quality-by-design perspective on manufacturability
AU  - Adithya Nair
AU  - Zoltán Kis
PY  - 2026
JO  - Biotechnology Advances
DO  - 10.1016/j.biotechadv.2026.109034
UR  - https://doi.org/10.1016/j.biotechadv.2026.109034
ER  - 

APA

Nair, A., & Kis, Z. (2026). In vitro transcription for RNA vaccines and therapeutics: a quality-by-design perspective on manufacturability. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2026.109034

Source records